Michael G. King Jr.

Insider Reports History

Location
Sioux Falls, SD
Signature
/s/ Michael G. King, Jr.
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael G. King Jr.:

Company Role Class Num Shares Value Price $ Report Date Ownership
SAB Biotherapeutics, Inc. CHIEF FINANCIAL OFFICER Common Stock 5,000 $4,400 $0.8800 30 Nov 2023 Direct
SAB Biotherapeutics, Inc. CHIEF FINANCIAL OFFICER Employee Stock Option (right to buy) 115,000 21 Feb 2024 Direct

Insider Reports Filed by Michael G. King Jr.

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SABS SAB Biotherapeutics, Inc. 21 Feb 2024 1 $0 4 CHIEF FINANCIAL OFFICER 23 Feb 2024, 16:45
SABS SAB Biotherapeutics, Inc. 30 Nov 2023 1 +$4,500 4 CHIEF FINANCIAL OFFICER 30 Nov 2023, 17:00
SABS SAB Biotherapeutics, Inc. 30 Oct 2023 1 $0 4 CHIEF FINANCIAL OFFICER 03 Nov 2023, 16:50
SABS SAB Biotherapeutics, Inc. 30 Oct 2023 0 $0 3 CHIEF FINANCIAL OFFICER 03 Nov 2023, 16:40